ADMA Biologics Inc (NASDAQ:ADMA)

4.92
Delayed Data
As of 4:00pm ET
 -0.21 / -4.09%
Today’s Change
2.01
Today|||52-Week Range
5.50
+53.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues2.6M3.4M4.7M12.0M
 
 
 
 
 
Cost of Goods Sold3.0M5.7M12.3M13.2M
 
 
 
 
 
Depreciation And Amortization118.1K277.1K836.1K1.5M
 
 
 
 
 
 
Operating ExpensesGross Income-466.9K-2.6M-8.4M-2.6M
 
 
 
 
 
General Expenses5.5M5.8M6.0M2.8M
 
 
 
 
 
Research And Development1.2M1.4M1.8M1.9M
 
 
 
 
 
Total Operating Expenses8.6M11.8M19.2M17.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.9M-8.4M-14.4M-5.5M
 
 
 
 
 
Extraordinary Charge0.00--0.00-6.3M
 
 
Interest Expense On Debt618.5K642.5K783.0K1.2M
 
 
 
 
 
Other Expenses0.000.000.00-10.1K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.5M-9.0M-15.2M-13.0M
 
 
 
 
 
Net Income-6.5M-9.0M-15.2M-13.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--16.4M25.8M45.3M
 
 
 
 
Shares To Calculate EPS Diluted--16.4M25.8M45.3M
 
 
 
 
 
Earnings Per ShareEPS-$0.51-$0.55-$0.59-$0.29
 
 
 
 
 
EPS Diluted---$0.55-$0.59-$0.29